Literature DB >> 32563863

DHA-enriched fish oil reduces insulin resistance in overweight and obese adults.

K A Abbott1, T L Burrows2, S Acharya3, R N Thota4, M L Garg5.   

Abstract

Adipose tissue inflammation is major factor in the development of insulin resistance (IR). Long-chain omega-3 polyunsaturated fatty acids (LCn-3PUFA) docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) are anti-inflammatory bioactive lipids, thus may protect against type 2 diabetes (T2D) development. Previous research has demonstrated a sex-dependent association between LCn-3PUFA and T2D, and evidence suggests LCn-3PUFA may improve IR in a sex-dependent manner. This double-blind, randomized, parallel-arm placebo-controlled study aimed to determine whether DHA-enriched fish oil (FO) supplementation improves IR. Sex-dependent effects were assessed by testing for an interaction between sex and treatment in the multiple regression models. Men and women with abdominal obesity (waist circumference: males, ≥102 cm; females, ≥88 cm) and without diabetes were recruited from the community. Participants (age: 50.9 ± 12.7 years, female: 63.7%, BMI: 32.4 ± 6.6 kg/m2) were randomly allocated to either 2 g FO (860 mg DHA + 120 mg EPA) (intervention, n = 38) or 2 g corn oil (CO) /day (control, n = 35) for 12 weeks in a double-blind randomised controlled trial. A fasting blood sample was collected at 0 and 12 weeks for assessment of IR, glucose and blood lipid profile. Sixty-eight participants completed the intervention. Compared with CO (n = 32), FO (n = 36) significantly reduced fasting insulin by -1.62 μIU/L (95%CI: -2.99, -0.26,) (p = 0.021) and HOMA-IR by -0.40 units (95%CI: -0.78, -0.02, p = 0.038). Higher insulin and HOMA-IR at baseline were associated with greater reductions in the FO group (p < 0.001). There was no interaction between sex and treatment for the change in insulin (p-interactionsex*treatment = 0.816) or HOMA-IR (p-interactionsex*treatment = 0.825). DHA-enriched FO reduces IR in adults with abdominal obesity, however, sex-dependent differences were not evident in this study.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Diabetes; Docosahexaenoic acid; Insulin resistance; Obesity; Omega-3; Polyunsaturated fatty acids

Mesh:

Substances:

Year:  2020        PMID: 32563863     DOI: 10.1016/j.plefa.2020.102154

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  5 in total

1.  SPM pathway marker analysis of the brains of obese mice in the absence and presence of eicosapentaenoic acid ethyl esters.

Authors:  Matthew Vander Ploeg; Kevin Quinn; Michael Armstrong; Jonathan Manke; Nichole Reisdorph; Saame Raza Shaikh
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2021-11-01       Impact factor: 4.006

2.  Association of Oily and Nonoily Fish Consumption and Fish Oil Supplements With Incident Type 2 Diabetes: A Large Population-Based Prospective Study.

Authors:  Guo-Chong Chen; Rhonda Arthur; Li-Qiang Qin; Li-Hua Chen; Zhendong Mei; Yan Zheng; Yang Li; Tao Wang; Thomas E Rohan; Qibin Qi
Journal:  Diabetes Care       Date:  2021-01-11       Impact factor: 19.112

3.  Serum Levels of Plasmalogens and Fatty Acid Metabolites Associate with Retinal Microangiopathy in Participants from the Finnish Diabetes Prevention Study.

Authors:  Vanessa Derenji de Mello; Tuomas Selander; Jaana Lindström; Jaakko Tuomilehto; Matti Uusitupa; Kai Kaarniranta
Journal:  Nutrients       Date:  2021-12-14       Impact factor: 5.717

Review 4.  Bioactive Compounds and Therapeutics from Fish: Revisiting Their Suitability in Functional Foods to Enhance Human Wellbeing.

Authors:  Chinaza Godswill Awuchi; Charles Nnanna Chukwu; Adams Ovie Iyiola; Sana Noreen; Sonia Morya; Ademiku O Adeleye; Hannington Twinomuhwezi; Katarzyna Leicht; Nancy Bonareri Mitaki; Charles Odilichukwu R Okpala
Journal:  Biomed Res Int       Date:  2022-08-05       Impact factor: 3.246

5.  Bioavailability of Orally Administered Active Lipid Compounds from four Different Greenshell™ Mussel Formats.

Authors:  Matthew R Miller; Marlena C Kruger; Chris Wynne; Devonie Waaka; Weili Li; Chris Frampton; Fran M Wolber; Charles Eason
Journal:  Mar Drugs       Date:  2020-10-23       Impact factor: 5.118

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.